6. You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected growth rate of 5% after 2003. 1998 1999 2000 2001 2002 2003 Net Sales 8,500 15,000 35,500 46,000 52,000 60,000 24,400 Cost of Sales 3,100 5,500 13,900 18,000 20,000 Depreciation 100 100 100 100 100 100 SG&A 3,500 5,410 6,400 5,300 7,200 7,800 7,000 R&D 1,100 2,800 4,100 5,400 6,500 1,190 417 EBIT 700 11,000 17,200 18,200 20,700 Income Tax (35%) 6,370 245 455 3.850 6,020 7,245 Net Earnings Depreciation Operating Cash Flows 774 7,150 11,180 11,830 13,455 Net PPE (906) (2,030) (1394) (900) (800) (300) (200) Working Capital (780) (2457) (1267) (738) (912) Terminal Value Free Cash Flows

EBK CONTEMPORARY FINANCIAL MANAGEMENT
14th Edition
ISBN:9781337514835
Author:MOYER
Publisher:MOYER
Chapter11: Capital Budgeting And Risk
Section: Chapter Questions
Problem 20P
icon
Related questions
Question

Estimate the free cash flows ('98-'03), the terminal value of the Canopy project in 2003 & the free cash flow, the NPV, the IRR, and the payback period.

6.
You are considering a geographic expansion into the European market for Canopy
Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your
analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected
growth rate of 5% after 2003.
1998
1999
2000
2001
2002
2003
Net Sales
8,500
15,000
35,500
46,000
52,000
60,000
Cost of Sales
3,100
5,500
13,900
18,000
20,000
24,400
Depreciation
100
100
100
100
100
100
SG&A
3,500
5,410
6,400
5,300
7,200
7,800
4,100
11,000
R&D
1,100
2,800
5,400
6,500
7,000
EBIT
700
1,190
17,200
18,200
20,700
Income Tax (35%)
245
6,020
417
774
3,850
6.370
7,245
7,150
Net Earnings
Depreciation
Operating Cash Flows
455
11,180
11,830
13,455
Net PPE
(906)
(1394)
(780)
(900)
(800)
(300)
(200)
Working Capital
(2,030)
(2457)
(1267)
(738)
(912)
Terminal Value
Free Cash Flows
Transcribed Image Text:6. You are considering a geographic expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected growth rate of 5% after 2003. 1998 1999 2000 2001 2002 2003 Net Sales 8,500 15,000 35,500 46,000 52,000 60,000 Cost of Sales 3,100 5,500 13,900 18,000 20,000 24,400 Depreciation 100 100 100 100 100 100 SG&A 3,500 5,410 6,400 5,300 7,200 7,800 4,100 11,000 R&D 1,100 2,800 5,400 6,500 7,000 EBIT 700 1,190 17,200 18,200 20,700 Income Tax (35%) 245 6,020 417 774 3,850 6.370 7,245 7,150 Net Earnings Depreciation Operating Cash Flows 455 11,180 11,830 13,455 Net PPE (906) (1394) (780) (900) (800) (300) (200) Working Capital (2,030) (2457) (1267) (738) (912) Terminal Value Free Cash Flows
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Capital Budgeting
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
EBK CONTEMPORARY FINANCIAL MANAGEMENT
EBK CONTEMPORARY FINANCIAL MANAGEMENT
Finance
ISBN:
9781337514835
Author:
MOYER
Publisher:
CENGAGE LEARNING - CONSIGNMENT
International Financial Management
International Financial Management
Finance
ISBN:
9780357130698
Author:
Madura
Publisher:
Cengage